Track topics on Twitter Track topics that are important to you
Experienced entrepreneur and investor appointed with immediate effect PredictImmune, developers of pioneering prognostic tools for guiding treatment options and improving patient outcomes in immune-...
PredictImmune announces new framework agreement with Cambridge Enterprise to allow future expansion of original IP license to expand its commercial product pipeline; extending the benefits of prognostic testing to include systemic lupus erythematosus
The agreement will enable PredictImmune to broaden its product range through the development and commercialisation of a prognostic test for SLE PredictImmune, developers of pioneering prognostic to...
Evaluation by the Diagnostic Assessment Programme provides independent support and validation of PredictImmune’s first product addressing IBD PredictImmune, developer...
US patent protects PredictImmune’s intellectual property relating to methods for predicting autoimmune disease risk PredictImmune, developers of pioneering prognostic tools ...
The CE-marked prognostic test for guiding treatment options uses a gene expression “signature”.
Developers of pioneering prognostic tools recognised for its innovative product development and contribution to life science discovery PredictImmune, developers of pioneering ...
We have published hundreds of PredictImmune news stories on BioPortfolio along with dozens of PredictImmune Clinical Trials and PubMed Articles about PredictImmune for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of PredictImmune Companies in our database. You can also find out about relevant PredictImmune Drugs and Medications on this site too.